Envoy Medical, Inc. Price & Performance (COCHW)

Envoy Medical has been notified by Nasdaq of non-compliance with the minimum $35 million market value rule, putting its listing at risk unless corrected by August 25. Meanwhile, the company has expanded its patent portfolio with new U.S., Japanese, and Hong Kong patents, signaling ongoing innovation in hearing health.12

PepsiCo's market share in the beverage segment remained robust at 53.64% in Q1 2025, far outpacing Coca-Cola at 27.48% and Keurig Dr Pepper at 8.96%. The company's strong performance underscores its continued leadership despite shifting consumer preferences and heightened competition in the sector.34

Tanzania’s 2024 portfolio review shows an increase in average project size and a reduction in problem projects, attributed to improved monitoring and faster disbursement processes. However, the number of ageing and potentially problematic projects slightly increased, prompting continued efforts to streamline government review procedures.51